Optimal Carbon Monoxide Criteria to Confirm Smoking Status Among Postpartum Women

Nicotine and Tobacco Research

Volumn 18, Issue 5, 2016, Pages

  Emery, Rebecca L ^a   Levine, Michele D ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CARBON MONOXIDE; COTININE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLACK PERSON; CAUCASIAN; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; MATERNAL SMOKING; PREDICTIVE VALUE; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; SALIVA LEVEL; SENSITIVITY AND SPECIFICITY; BREATH ANALYSIS; CHEMISTRY; SALIVA; SMOKING; YOUNG ADULT;

ADULT; BREATH TESTS; CARBON MONOXIDE; COTININE; FEMALE; HUMANS; POSTPARTUM PERIOD; PREGNANCY; ROC CURVE; SALIVA; SMOKING; YOUNG ADULT;

EID: 84964940141     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntv196     Document Type: Article

References (37)

1. Zang EA, Wynder EL. Differences in lung cancer risk between men and women: examination of the evidence. J Natl Cancer Inst. 1996;88(3-4):183-192. www.ncbi.nlm.nih.gov/pubmed/8632492. Accessed June 2, 2015.
2. Castelao JE, Yuan JM, Skipper PL, et al. Gender- and smoking-related bladder cancer risk. J Natl Cancer Inst. 2001;93(7):538-545. doi:10.1093/jnci/93.7.538.
3. Castle PE, Wacholder S, Lorincz AT, et al. A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women. J Natl Cancer Inst. 2002;94(18):1406-1414. doi:10.1093/jnci/94.18.1406.
4. Baron JA, LaVecchia C, Levi F. The antiestrogenic effect of cigarette smoking in women. Am J Obstet Gynecol. 1990;162(2):504-514. doi:10.1016/0002-9378(90)90420-C.
5. Prescott E, Hippe M, Schrohr P, de Heis H, Vestbo J. Smoking and risk of myocardial infarction in women and men: longitudinal population study. BMJ. 1998;316(7137):1043-1047. doi:http://dx.doi.org/10.1136/bmj.316.7137.1043.
6. Dybing E, Sanner T. Passive smoking, sudden infant death syndrome (SIDS) and childhood infections. Hum Exp Toxicol. 1999;18(4):202-205. www.ncbi.nlm.nih.gov/pubmed/10333302. Accessed June 2, 2015.
7. Ey JL, Holberg CJ, Aldous MB, Wright AL, Martinez FD, Taussig LM. Passive smoking exposure and otitis media in the first year of life: Group Health Medical Associates. Pediatrics. 1995;95(5):670-677. www.ncbi.nlm.nih.gov/pubmed/7724301. Accessed June 2, 2015.
8. Maughan B, Taylor C, Taylor A, Butler N, Bynner J. Pregnancy smoking and childhood conduct problems: a causal association? J Child Psychol Psychiatry. 2001;42(8):1021-1028. doi:http://dx.doi.org/10.1017/S0021963001007880.
9. Cornelius MD, Day NL. The effects of tobacco use during and after pregnancy on exposed children. Alcohol Res Health. 2000;24(4):242-249. www.ncbi.nlm.nih.gov/pubmed/15986719. Accessed June 2, 2015.
10. Kahn RS, Zuckerman B, Bauchner H, Homer CJ, Wise PH. Women-s health after pregnancy and child outcomes at age 3 years: a prospective cohort study. Am J Public Health. 2002;92(8):1312-1318. doi:10.2105/AJPH.92.8.1312.
11. Fingerhut LA, Kleinman JC, Kendrick JS. Smoking before, during, and after pregnancy. Am J Public Health. 1990;80(5):541-544. doi:10.2105/AJPH.80.5.541.
12. McBride CM, Pirie PL. Postpartum smoking relapse. Addict Behav. 1990;15(2):165-168. doi:0306-4603(90)90020-X.
13. Mullen PD, Quinn VP, Ershoff DH. Maintenance of nonsmoking postpartum by women who stopped smoking during pregnancy. Am J Public Health. 1990;80(8):992-994. doi:10.2105/AJPH.80.8.992.
14. SRNT Subcommittee on Biochemical Verification. Biochemical verification of tobacco use and cessation. Nicotine Tob Res. 2002;4(2):149-159. doi:10.1080/14622200210123581.
15. Russell T, Crawford M, Woodby L. Measurements for active cigarette smoke exposure in prevalence and cessation studies: why simply asking pregnant women isn-t enough. Nicotine Tob Res. 2004;6(2):S141-151. doi:10.1080/14622200410001669141.
16. Higgins ST, Heil SH, Badger GJ, et al. Biochemical verification of smoking status in pregnant and recently postpartum women. Exp Clin Psychopharmacol. 2007;15(1):58-66. doi:10.1037/1064-1297.15.1.58.
17. Jarvis MJ, Tunstall-Pedoe H, Feyerabend C, Vesey C, Saloojee Y. Comparison of tests used to distinguish smokers from nonsmokers. Am J Public Health. 1987;77(11):1435-1438. doi:10.2105/AJPH.77.11.1435.
18. Benowitz NL. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev. 1996;18(2):188-204. www.ncbi.nlm.nih.gov/pubmed/9021312. Accessed June 2, 2015.
19. Rebagliato M. Validation of self reported smoking. J Epidemiol Community Health. 2002;56(3):163-164. doi:10.1136/jech.56.3.163.
20. Dempsey D, Jacob P III, Benowitz NL. Accelerated metabolism of nicotine and cotinine in pregnant smokers. J Pharmacol Exp Ther. 2002;301(2):594-598. doi:10.1124/jpet.301.2.594.
21. Marrone GF, Paulpillai M, Evans RJ, Singleton EG, Heishman SJ. Breath Carbon Monoxide and Semiquantitative Saliva Cotinine as Biomarkers for Smoking. Human Psychopharmacol. 2010;25(1):80-83. doi:10.1002/hup.1078.
22. Cropsey KL, McClure LA, Jackson DO, Villalobos GC, Weaver MF, Stitzer ML. The impact of quitting smoking on weight among women prisoners participating in a smoking cessation intervention. Am J Public Health. 2010;100(8):1442-1448. doi:10.2105/AJPH.2009.172783.
23. Jones MR, Apelberg BJ, Tellez-Plaza M, Samet JM, Navas-Acien A. Menthol cigarettes, race/ethnicity, and biomarkers of tobacco use in U.S. adults: the 1999-2010 National Health and Nutrition Examination Survey (NHANES). Cancer Epidemiol Biomarkers Prev. 2013;22(2):224- 232. doi:10.1158/1055-9965.epi-12-0912.
24. Perez-Stable EJ, Herrera B, Jacob P III, Benowitz NL. Nicotine metabolism and intake in black and white smokers. JAMA. 1998;280(2):152-156. doi:10.1001/jama.280.2.152.
25. Benowitz NL, Hukkanen J, Jacob P III. Nicotine chemistry, metabolism, kinetics and biomarkers. Nic Psychopharmacol. 2009;192:29-60. doi:10.1007/978-3-540-69248-5_2.
26. Levine MD, Marcus MD, Kalarchian MA, Cheng Y. Strategies to Avoid Returning to Smoking (STARTS): a randomized controlled trial of postpartum smoking relapse prevention interventions. Contemp Clin Trials. 2013;36(2):565-573. doi:10.1016/j.cct.2013.10.002.
27. Brown RS, Burgess ES, Sales SD, Whiteley JA, Evans DM, Miller IW. Reliability and validity of a smoking timeline followback interview. Psychol Addict Behav. 1998;12(2):101-112. doi:10.1037/0893-164X.12.2.101.
28. Ossip-Klein DJ, Bigelow G, Parker SR, Curry S, Hall S, Kirkland S. Classification and assessment of smoking behavior. Health Psychol. 1986;5:3-11. www.ncbi.nlm.nih.gov/pubmed/3582323. Accessed June 2, 2015.
29. Hughes JR, Keely JP, Niaura RS, Ossip-Klein DJ, Richmond RL, Swan GE. Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob Res. 2003;5(1):13-25. doi:10.1093/ntr/5.1.13.
30. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem. 1993;39(4):561-577. www.clinchem.org/content/39/4/561.short. Accessed June 2, 2015.
31. Javors MA, Hatch JP, Lamb RJ. Cut-off levels for breath carbon monoxide as a marker for cigarette smoking. Addiction. 2005;100(2):159-167. doi:10.1111/j.1360-0443.2004.00957.x.
32. Usmani ZC, Craig P, Shipton D, Tappin D. Comparison of CO breath testing and women-s self-reporting of smoking behaviour for identifying smoking during pregnancy. Subst Abuse Treat Prev Policy. 2008;3:4. doi:10.1186/1747-597X-3-4.
33. Perkins KA, Karelitz JL, Jao NC. Optimal carbon monoxide criteria to confirm 24-hr smoking abstinence. Nicotine Tob Res. 2013;15(5):978- 982. doi:10.1093/ntr/nts205.
34. Cropsey KL, Trent LR, Clark CB, Stevens EN, Lahti AC, Hendricks PS. How low should you go? Determining the optimal cutoff for exhaled carbon monoxide to confirm smoking abstinence when using cotinine as reference. Nicotine Tob Res. 2014;16(10):1348-1355. doi:10.1093/ntr/ntu085.
35. Kraemer HC, Kupfer DJ. Size of treatment effects and their importance to clinical research and practice. Biol Psychiatry. 2006;59(11):990-996. doi:10.1016/j.biopsych.2005.09.014.
36. Joseph AM, Hecht SS, Murphy SE, et al. Relationships between cigarette consumption and biomarkers of tobacco toxin exposure. Cancer Epidemiol Biomarkers Prev. 2005;14(12):2963-2968. doi:10.1158/1055-9965.epi-04-0768.
37. Jarvis MJ, Primatesta P, Erens B, Feyerabend C, Bryant A. Measuring nicotine intake in population surveys: comparability of saliva cotinine and plasma cotinine estimates. Nicotine Tob Res. 2003;5(3):349-355. doi:10.1080/1462220031000094213.